142 related articles for article (PubMed ID: 11111841)
1. Comparison of the effects of epibatidine and nicotine on the output of dopamine in the dorsal and ventral striatum of freely-moving rats.
Seppä T; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):444-7. PubMed ID: 11111841
[TBL] [Abstract][Full Text] [Related]
2. Nicotine and epibatidine alter differently nomifensine-elevated dopamine output in the rat dorsal and ventral striatum.
Janhunen S; Tuominen RK; Piepponen TP; Ahtee L
Eur J Pharmacol; 2005 Mar; 511(2-3):143-50. PubMed ID: 15792782
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
Janhunen S; Ahtee L
Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
[TBL] [Abstract][Full Text] [Related]
4. Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats.
Bednar I; Friberg L; Nordberg A
Neurochem Int; 2004 Dec; 45(7):1049-55. PubMed ID: 15337304
[TBL] [Abstract][Full Text] [Related]
5. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S; Mielikäinen P; Paldánius P; Tuominen RK; Ahtee L; Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):480-91. PubMed ID: 16012872
[TBL] [Abstract][Full Text] [Related]
6. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
7. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Kulak JM; McIntosh JM; Quik M
Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures.
Seppä T; Ruotsalainen M; Laakso I; Tuominen R; Ahtee L
Br J Pharmacol; 2000 Jul; 130(5):1147-55. PubMed ID: 10882401
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Janhunen S; Tuominen RK; Ahtee L
Neurosci Lett; 2005 Jun; 381(3):314-9. PubMed ID: 15896491
[TBL] [Abstract][Full Text] [Related]
10. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
[TBL] [Abstract][Full Text] [Related]
11. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
Mellon RD; Bayer BM
J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
[TBL] [Abstract][Full Text] [Related]
12. Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum.
Puttfarcken PS; Jacobs I; Faltynek CR
Neuropharmacology; 2000 Oct; 39(13):2673-80. PubMed ID: 11044737
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.
Reuben M; Boye S; Clarke PB
Eur J Pharmacol; 2000 Mar; 393(1-3):39-49. PubMed ID: 10770996
[TBL] [Abstract][Full Text] [Related]
14. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
16. Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats.
Janhunen S; Linnervuo A; Svensk M; Ahtee L
Pharmacol Biochem Behav; 2005 Dec; 82(4):758-65. PubMed ID: 16413603
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.
Jacobs I; Anderson DJ; Surowy CS; Puttfarcken PS
Neuropharmacology; 2002 Oct; 43(5):847-56. PubMed ID: 12384170
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
19. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
[TBL] [Abstract][Full Text] [Related]
20. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.
Marubio LM; Gardier AM; Durier S; David D; Klink R; Arroyo-Jimenez MM; McIntosh JM; Rossi F; Champtiaux N; Zoli M; Changeux JP
Eur J Neurosci; 2003 Apr; 17(7):1329-37. PubMed ID: 12713636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
